The Gross Margin of Guizhou Sanli Pharmaceutical Co Ltd (603439.SS) is 73.17%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2023-12-31 | 73.17% |
2022-12-31 | 71.74% |
2021-12-31 | 70.49% |
2020-12-31 | 66.84% |
2019-12-31 | 66.19% |
2018-12-31 | 65.42% |
2017-12-31 | 66.44% |
2016-12-31 | 65.04% |
2015-12-31 | 62.23% |
2014-12-31 | 60.58% |